Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Receptors, Androgen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05682443
What this trial is testing

ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
OncoC4, Inc. 148
Post-approval studies (Phase 4)Active Not RecruitingNCT04597125
What this trial is testing

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Bayer 654
Testing effectiveness (Phase 2)Study completedNCT02091960
What this trial is testing

Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

Who this might be right for
HER2 AmplifiedAdvanced Breast CancerHuman Epidermal Growth Factor Receptor 2 (HER2)
Astellas Pharma Global Development, Inc. 103
Not applicableLooking for participantsNCT07406282
What this trial is testing

Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

Who this might be right for
Prostatic NeoplasmsMetastatic Hormone-Sensitive Prostate Cancer
Bayer 1,400
Early research (Phase 1)Study completedNCT02045940
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of GSK2881078 in Single and Repeat Doses

Who this might be right for
Cachexia
GlaxoSmithKline 99
Large-scale testing (Phase 3)Looking for participantsNCT05352178
What this trial is testing

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+4 more
Universitaire Ziekenhuizen KU Leuven 873
Not applicableLooking for participantsNCT06473259
What this trial is testing

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerHormone Sensitive Prostate CancerMetastatic Tumor
Santa Chiara Hospital 3,000
Testing effectiveness (Phase 2)UnknownNCT03050866
What this trial is testing

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)

Who this might be right for
Circulating Tumor CellMetastatic Prostate Cancer
Erasmus Medical Center 140
Early research (Phase 1)Ended earlyNCT05673109
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 8
Early research (Phase 1)Study completedNCT01162395
What this trial is testing

Open Label Prostate Cancer Study

Who this might be right for
Prostate Cancer
AstraZeneca 64
Early research (Phase 1)Ended earlyNCT05839119
What this trial is testing

Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant

Who this might be right for
Urothelial Carcinoma BladderAndrogen Receptor Positive
Brown University 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT02949284
What this trial is testing

Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Rutgers, The State University of New Jersey 90
Testing effectiveness (Phase 2)Study completedNCT01534052
What this trial is testing

Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)
Astellas Pharma Inc 52
Testing effectiveness (Phase 2)UnknownNCT06108193
What this trial is testing

Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris

Who this might be right for
Acne Vulgaris
Chang Gung Memorial Hospital 26
Large-scale testing (Phase 3)Active Not RecruitingNCT06691984
What this trial is testing

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 707
Large-scale testing (Phase 3)Looking for participantsNCT07260435
What this trial is testing

Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Nick Beije 400
Testing effectiveness (Phase 2)Looking for participantsNCT07202247
What this trial is testing

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

Who this might be right for
Prostate CarcinomaRecurrent Prostate Carcinoma
City of Hope Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06854250
What this trial is testing

Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sun Yat-sen University 104
Not applicableStudy completedNCT02118636
What this trial is testing

Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms

Who this might be right for
Breast CancerArthralgia
Lynn Henry 75
Large-scale testing (Phase 3)Not Yet RecruitingNCT07760844
What this trial is testing

An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Everolimus in First to Third Line LAR Subtype TNBC

Who this might be right for
Breast CancerTriple Negative Breast Cancer (TNBC)
Fudan University 180
Next Page